12118027

Source:http://linkedlifedata.com/resource/pubmed/id/12118027

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0002475, umls-concept:C0016360, umls-concept:C0034656, umls-concept:C0205187, umls-concept:C0282461, umls-concept:C0346647, umls-concept:C0348013, umls-concept:C0574032
pubmed:issue	14
pubmed:dateCreated	2002-7-15
pubmed:abstractText	To compare protracted venous infusion (PVI) fluorouracil (5-FU) with PVI 5-FU plus mitomycin (MMC) in patients with advanced pancreatic cancer in a multicenter, prospectively randomized study.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8309333
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antibiotics, Antineoplastic, http://linkedlifedata.com/resource/pubmed/chemical/Antimetabolites, Antineoplastic, http://linkedlifedata.com/resource/pubmed/chemical/Fluorouracil, http://linkedlifedata.com/resource/pubmed/chemical/Mitomycin
pubmed:status	MEDLINE
pubmed:month	Jul
pubmed:issn	0732-183X
pubmed:author	pubmed-author:CroyR DRD, pubmed-author:CunninghamDavidD, pubmed-author:HarringtonAngelaA, pubmed-author:HickishTamasT, pubmed-author:HillMarkM, pubmed-author:IvesonTimT, pubmed-author:MaiseyNickN, pubmed-author:NormanAndrewA, pubmed-author:O'BrienMaryM, pubmed-author:SeymourMattM, pubmed-author:TebbuttNiallN
pubmed:issnType	Print
pubmed:day	15
pubmed:volume	20
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	3130-6
pubmed:dateRevised	2006-4-24
pubmed:meshHeading	pubmed-meshheading:12118027-Adult, pubmed-meshheading:12118027-Aged, pubmed-meshheading:12118027-Aged, 80 and over, pubmed-meshheading:12118027-Antibiotics, Antineoplastic, pubmed-meshheading:12118027-Antimetabolites, Antineoplastic, pubmed-meshheading:12118027-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:12118027-Drug Administration Schedule, pubmed-meshheading:12118027-Female, pubmed-meshheading:12118027-Fluorouracil, pubmed-meshheading:12118027-Humans, pubmed-meshheading:12118027-Infusions, Intravenous, pubmed-meshheading:12118027-Male, pubmed-meshheading:12118027-Middle Aged, pubmed-meshheading:12118027-Mitomycin, pubmed-meshheading:12118027-Pancreatic Neoplasms, pubmed-meshheading:12118027-Quality of Life, pubmed-meshheading:12118027-Survival Analysis, pubmed-meshheading:12118027-Treatment Outcome
pubmed:year	2002
pubmed:articleTitle	Multicenter randomized phase III trial comparing protracted venous infusion (PVI) fluorouracil (5-FU) with PVI 5-FU plus mitomycin in inoperable pancreatic cancer.
pubmed:affiliation	Royal Marsden Hospital, Surrey, United Kingdom.
pubmed:publicationType	Journal Article, Clinical Trial, Randomized Controlled Trial, Multicenter Study, Clinical Trial, Phase III